BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2018
Shares 84,855 Value ($000) $685 Avg Close $7.78 Range $6.43 - $9.71
Q3 2018
Shares 144,000 Value ($000) $1,099 Avg Close $6.72 Range $5.41 - $8.13
Q2 2018
Shares 144,000 Value ($000) $825 Avg Close $5.50 Range $4.53 - $6.67
Q1 2018
Shares 144,000 Value ($000) $687 Avg Close $5.14 Range $4.25 - $5.92
Q4 2017
Shares 144,000 Value ($000) $707 Avg Close $4.84 Range $4.12 - $5.35
Q3 2017
Shares 144,000 Value ($000) $755 Avg Close $5.12 Range $3.95 - $6.22
Q2 2017
Shares 144,000 Value ($000) $801 Avg Close $6.09 Range $5.02 - $8.80
Q1 2017
Shares 144,000 Value ($000) $1,210 Avg Close $6.96 Range $4.20 - $9.25
Q4 2016
Shares 144,000 Value ($000) $912 Avg Close $5.20 Range $3.75 - $7.56
Q3 2016
Shares 160,000 Value ($000) $706 Avg Close $3.99 Range $2.82 - $5.80
Q2 2016
Shares 160,000 Value ($000) $454 Avg Close $3.10 Range $2.49 - $4.03
Q1 2016
Shares 160,000 Value ($000) $453 Avg Close $4.43 Range $1.63 - $10.24